Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The effectiveness and safety of neoadjuvant chemotherapy of Abraxane combined with cisplatin, concurrent chemotherapy of cisplatin and IMRT in local-regionally advanced nasopharyngeal carcinoma : a prospective, non-controlled clinical trial

Trial Profile

The effectiveness and safety of neoadjuvant chemotherapy of Abraxane combined with cisplatin, concurrent chemotherapy of cisplatin and IMRT in local-regionally advanced nasopharyngeal carcinoma : a prospective, non-controlled clinical trial

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Jul 2017

At a glance

  • Drugs Cisplatin (Primary) ; Paclitaxel (Primary)
  • Indications Carcinoma; Nasopharyngeal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top